The Performance of the Abbott Real Time MTB RIF/INH Compared to the MTBDRplus V2 for the Identification of MDR-TB Among Isolates

References

• Tanna GLD, Khaki AR, Theron G, et al. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis. Lancet Glob Health. 2019;7(2):91–99. doi:10.1016/S2214-109X(18)30458-3
   Web of Science ®Google Scholar
• Berhanu RH, David A, da Silva P, et al. Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott Real Time MTB for the diagnosis of pulmonary tuberculosis in a high HIV burden setting. J Clin Microbiol. 2018;56(12):e00560–e00518. doi:10.1128/JCM.00560-1830305387
   PubMed Web of Science ®Google Scholar
• Bai Y, Wang Y, Shao C, Hao Y, Jin Y. GenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-Analysis. PLoS One. 2016;11:3.
   Google Scholar
• Meaza A, Kebede A, Yaregal Z, et al. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. BMC Infect Dis. 2017;17(1):280. doi:10.1186/s12879-017-2389-628415989
   PubMed Web of Science ®Google Scholar
• Seifert M, Ajbani K, Georghiou SB, et al. A Performance Evaluation of MTBDRplus (version 2) for the Diagnosis of Multidrug-resistant Tuberculosis. Int J Tuberc Lung Dis. 2016;20(5):631–637. doi:10.5588/ijtld.15.078827084817
   PubMed Web of Science ®Google Scholar
• Barnard M, Gey van Pittius NC, van Helden PD, Bosman M, Coetzee G, Warren RM. The Diagnostic Performance of the GenoType MTBDRplus Version 2 Line Probe Assay Is Equivalent to That of the Xpert MTB/RIF Assay. Journal Clin Microbiol. 2012;50(11):3712–3716. doi:10.1128/JCM.01958-12
   Web of Science ®Google Scholar
• WHO. Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multi-Drug Resistant Tuberculosis (MDR-TB). Geneva, Switzerland: World Health Organization; 2008.
   Google Scholar
• Madhuri K, Deshpande S, Dharmashale S, Bharadwaj R. Utility of Line Probe Assay for the Early Detection of Multidrug-Resistant Pulmonary Tuberculosis. J Glob Infect Dis. 2015;7(2):60–65. doi:10.4103/0974-777X.15723726069424
   PubMed Web of Science ®Google Scholar
• Ahmed S, Shukla I, Fatima N, Varshney SK, Shameem M. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh. Indian J Med Microbiol. 2017;35:568–574.29405151
   PubMed Web of Science ®Google Scholar
• Crudu V, Stratan E, Romancenco E, Allerheiligen V, Hillemann A, Moraru N. First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances. J Clin Microbiol. 2012;50(4):1264–1269. doi:10.1128/JCM.05903-1122301019
   PubMed Web of Science ®Google Scholar
• Maningi NE, Malinga LA, Antiabong JF. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa. BMC Infect Dis. 2017;17:795.29282012
   PubMed Web of Science ®Google Scholar
• Scott LE, Carmona S, Gous N, Horsfield P, MacKay M, Stevens W. Use of a Prequalification Panel for Rapid Scale-Up of High-Throughput HIV Viral Load Testing. J Clin Microbiol. 2012;50(12):4083–4086. doi:10.1128/JCM.01355-1222993182
   PubMed Web of Science ®Google Scholar
• Wang MG, Xue M, Wu SQ, et al. Abbott RealTime MTB and MTB RIF/INH assays for the diagnosis of tuberculosis and rifampicin/isoniazid resistance. Infect Genet Evol. 2019;71:54–59. doi:10.1016/j.meegid.2019.03.01230902741
   PubMed Web of Science ®Google Scholar
• Scott LE, David A, Noble L, et al. Performance of the Abbott RealTime MTB and MTB RIF/INH Assays in a Setting of High Tuberculosis and HIV Coinfection in South Africa. J Clin Microbiol. 2017;55(8):2491–2501. doi:10.1128/JCM.00289-1728592547
   PubMed Web of Science ®Google Scholar
• Tam KK, Leung K, To SW, et al. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott RealTime MTB detection and RIF/INH resistance assay. Diagn Microbiol Infect Dis. 2017;89(2):118–124. doi:10.1016/j.diagmicrobio.2017.06.01828780247
   PubMed Web of Science ®Google Scholar
• Kostera J, Leckie G, Abravaya K, Wang H. Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh. Infect Drug Resist. 2018;11(11):695–699. doi:10.2147/IDR.S15895329785129
   PubMed Web of Science ®Google Scholar
• GenoType MTBDRplus Instructions for Use. Hain Lifesciences; 2018.
   Google Scholar
• GmbH HL GenoType MTBDR Plus, VER 2.0, Instructions for Use, IFU-304A-09 Germany2019. Available from: https://www.hain-lifescience.de/en/instructions-for-use.html. Accessed 9 4, 2020.
   Google Scholar
• Zaw MT, Emran NA, Lin Z. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health. 2018;11(5):605–610. doi:10.1016/j.jiph.2018.04.00529706316
   PubMed Web of Science ®Google Scholar
• Kapur V, Li L, Lordanescu S, et al. Characterization by Automated DNA Sequencing of Mutations in the Gene (rpoB) Encoding the RNA Polymerase 3 Subunit in Rifampin-Resistant Mycobacterium tuberculosis Strains from New York City and Texas. J Clin Microbiol. 1994;32(4):1095–1098. doi:10.1128/JCM.32.4.1095-1098.19948027320
   PubMed Web of Science ®Google Scholar
• Georghiou SB, Seifert M, Catanzaro D, et al. Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape. Antimicro Agents Chemother. 2016;60:3994–4004.
   Web of Science ®Google Scholar
• Miotto P, Tessema B, Tagliani E, et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J. 2017;50(6):1701354. doi:10.1183/13993003.01354-201729284687
   PubMed Web of Science ®Google Scholar
• Van Deun A, Aung KJ, Bola V, et al. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol. 2013;51(8):2633–2640. doi:10.1128/JCM.00553-1323761144
   PubMed Web of Science ®Google Scholar
• Ruiz P, Causse M, Vaquero M, Guitierrez JB, Casal M. Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis. Infect Drug Resist. 2017;10:463–467. doi:10.2147/IDR.S14727229263682
   PubMed Web of Science ®Google Scholar
• Hoffmann-Thiel S, Molodtsov N, Duffner C, et al. Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis. Int J Tuberc Lung Dis. 2019;23(4):458–464. doi:10.5588/ijtld.18.061531064625
   PubMed Web of Science ®Google Scholar
• Rahman A, Sahrin M, Afrin S, et al. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis. PLoS One. 2016;11(4):4. doi:10.1371/journal.pone.0152694
   Web of Science ®Google Scholar
• Seifert M, Catanzaro D, Catanzaro A, Rodwell TC. Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review. PLoS One. 2015;10(3):e0119628. doi:10.1371/journal.pone.011962825799046
   PubMed Web of Science ®Google Scholar
• Vinuesa V, Navarro D, Poujois S, Zaragoza S, Borras R. Performance characteristics of the new Abbott Real Time MTB assay for detection of Mycobacterium tuberculosis complex in respiratory specimens. Diagn Microbiol Infect Dis. 2016;84(3):212–214. doi:10.1016/j.diagmicrobio.2015.11.00126658312
   PubMed Web of Science ®Google Scholar
• Tang N, Frank A, Pahalawatta V, et al. Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimens. Tuberculosis. 2015;95(5):613–619. doi:10.1016/j.tube.2015.05.01026119174
   PubMed Web of Science ®Google Scholar
• Chen JH, She KK, Kwong TC, et al. Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens. Eur J Clin Microbiol Infect Dis. 2015;34(9):1827–1832. doi:10.1007/s10096-015-2419-526071001
   PubMed Web of Science ®Google Scholar
• Kostera J, Leckie G, Tang N, et al. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens. Tuberculosis. 2016;101:137–143. doi:10.1016/j.tube.2016.09.00627865383
   PubMed Web of Science ®Google Scholar
• Helb D, Jones M, Story E, et al. Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology. J Clin Microbiol. 2010;48(1):229–237. doi:10.1128/JCM.01463-0919864480
   PubMed Web of Science ®Google Scholar
• Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010;48(7):2495–2501. doi:10.1128/JCM.00128-1020504986
   PubMed Web of Science ®Google Scholar
• Chakravorty S, Simmons AM, Rowneki M, et al. The New Xpert MTB/RIF Ultra: improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing. mBio. 2017;8(4):e00812. doi:10.1128/mBio.00812-1728851844
   PubMed Web of Science ®Google Scholar
• Murray P, Cooper C, Maus C. Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays. J Clin Microbiol. 2019;57(9):e00779. doi:10.1128/JCM.00779-1931451572
   PubMed Web of Science ®Google Scholar
• de Vos M, Derendinge RB, Dolby T, et al. Diagnostic accuracy and utility of FluoroType MTBDR, a new molecular assay for multidrug-resistant tuberculosis. J Clin Microbiol. 2018;56(9). doi:10.1128/JCM.00531-18
   Web of Science ®Google Scholar
• Hillemann D, Haasis C, Andres S, Behn T, Kranzer K. Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates. J Clin Microbiol. 2018;56(6):e00072. doi:10.1128/JCM.00072-1829593055
   PubMed Web of Science ®Google Scholar
• Obasanya J, Lawson L, Edwards T, et al. FluoroType MTB system for the detection of pulmonary tuberculosis. ERJ Open Res. 2017;3:2.
   Google Scholar